Research Center of Clinical Epidemiology, Peking University Third Hospital, 49 North Garden Rd, Haidian District, Beijing, 100191, People's Republic of China.
Department of Nephrology, Peking University Third Hospital, 49 North Garden Rd, Haidian District, Beijing, 100191, People's Republic of China.
Int Urol Nephrol. 2020 Mar;52(3):565-571. doi: 10.1007/s11255-020-02389-y. Epub 2020 Feb 3.
Initial or single time point serum albumin levels have been shown to be important in predicting the prognosis of peritoneal dialysis (PD) patients. However, we assume the dynamic change and trend of albumin after PD are essential. We aimed to investigate the association between baseline albumin levels, albumin trajectories, and patient mortality in a retrospective cohort study.
In this retrospective cohort study, 547 incident PD patients were enrolled from Peking University Third Hospital. Date were collected by medical records review, including age, gender, body mass index, primary disease, comorbidities, and laboratory tests. A joint model for longitudinal data and time-to-event data was used to establish the relationship between serum albumin trajectories and mortality risk of PD patients.
The albumin trajectories was negatively correlated with risk of death. The increase in the current value of albumin trajectories at time points t after PD was associated with decreased risk of death (HR = 0.881, p < 0.0001). There was no statistical association between initial albumin and risk of death (HR = 1.030, 95% CI 0. 995-1.066). The results showed that increased age, higher albumin-corrected Ca levels, and higher eGFR values were risk factors for death. In addition, predictors of low albumin levels are increased PD time, increased age, increased albumin-corrected Ca, and decreased BMI as well as initial albumin levels.
This study demonstrates that albumin trajectories after PD is better than initial serum albumin level in predicting mortality risk. Increasing albumin level over time can improve the prognosis of PD patients.
已有研究表明,初始或单次血清白蛋白水平对预测腹膜透析(PD)患者的预后具有重要意义。然而,我们认为 PD 后白蛋白的动态变化和趋势至关重要。我们旨在通过回顾性队列研究调查基线白蛋白水平、白蛋白轨迹与患者死亡率之间的关系。
本回顾性队列研究纳入了 547 例来自北京大学第三医院的新诊断 PD 患者。通过病历回顾收集数据,包括年龄、性别、体重指数、原发病、合并症和实验室检查。采用纵向数据和生存时间数据联合模型来建立血清白蛋白轨迹与 PD 患者死亡风险之间的关系。
白蛋白轨迹与死亡风险呈负相关。PD 后时间点 t 时白蛋白轨迹的当前值增加与死亡风险降低相关(HR=0.881,p<0.0001)。初始白蛋白与死亡风险之间无统计学关联(HR=1.030,95%CI 0.995-1.066)。结果显示,年龄增加、白蛋白校正钙水平升高和 eGFR 值升高是死亡的危险因素。此外,白蛋白水平降低的预测因素包括 PD 时间延长、年龄增加、白蛋白校正钙升高、BMI 降低以及初始白蛋白水平。
本研究表明,PD 后白蛋白轨迹优于初始血清白蛋白水平,可更好地预测死亡率风险。白蛋白水平随时间增加可改善 PD 患者的预后。